← SynDRA
OMEPRAZOLE
SynDRA canonical compound SYN0008013 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ATP4A |
|---|
| Mechanism of action | ATPase inhibitor |
|---|
| Indication | heartburn |
|---|
| Disease area | gastroenterology |
|---|
All known targets
- ATP4A
- ATP4B
- CLCN2
- CYP1A2
- CYP2C19
- ABCB1
- ABCG2
- ATP4A; ATP4B
- CYP2C9
- CYP3A4
- DDAH1
- ENGASE
Mechanisms of action (all sources)
- ATPase inhibitor
- ATP4A INHIBITOR
- Potassium-transporting ATPase inhibitor
- ATP4B INHIBITOR
- CLCN2 MODULATOR
- proton pump inhibitor
- Modulator
Drug classes
- Proton Pump Inhibitors
- Proton Pump Inhibitor
- Anti-Ulcer Agents
- Enzyme Inhibitors
- Gastrointestinal Agents
- Cytochrome P450 2C19 Inhibitors
ATC classes
- A02B · DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
Cross-references
Synonyms
- omeprazole sodium
- omeprazole magnesium
- omeprazole sodium bicarbonate
- Omeprazol
- H-168/68
- NSC-751450
- NSC-759192
- Antra
- Losec
- Losec mups
- Mezzopram
- Mopral
- Omeprazole component of konvomep
- Omeprazole component of pa-32540
- Omeprazole component of yosprala
- Omeprazole component of zegerid
- Omeran
- Prilosec
- Zanprol
- Losec (TN)
- Omeprazon
- Audazol
- Omapren
- Omepral
- Parizac
- Zegerid
- Miol
- Belmazol
- Ceprandal
- Dizprazol
- Dudencer
- Emeproton
- Epirazole
- Gastrimut
- Gastroloc
- Gibancer
- Indurgan
- Inhibitron
Reported adverse events
- Hypersensitivity
- Stevens-Johnson syndrome
- Tinnitus
- Agranulocytosis
- Pancreatitis
- Headache
- Fracture
- Chest pain
- Epistaxis
- Optic atrophy
- Nausea
- Dizziness
Look up OMEPRAZOLE in the interactive SynDRA portal →